The stock of GeneDx Holdings Corp (WGS) has seen a 5.85% increase in the past week, with a -36.29% drop in the past month, and a -29.74% decrease in the past quarter. The volatility ratio for the week is 4.31%, and the volatility levels for the past 30 days are at 13.48% for WGS. The simple moving average for the last 20 days is -5.75% for WGS stock, with a simple moving average of -4.27% for the last 200 days.
Is It Worth Investing in GeneDx Holdings Corp (NASDAQ: WGS) Right Now?
Moreover, the 36-month beta value for WGS is 2.01. Analysts have varying opinions on the stock, with 5 analysts rating it as a “buy,” 0 as “overweight,” 3 as “hold,” and 0 as “sell.”
The public float for WGS is 24.97M and currently, short sellers hold a 14.30% of that float. On May 23, 2025, WGS’s average trading volume was 1.15M shares.
WGS) stock’s latest price update
GeneDx Holdings Corp (NASDAQ: WGS)’s stock price has decreased by -0.66 compared to its previous closing price of 67.78. However, the company has seen a 5.85% increase in its stock price over the last five trading sessions. businesswire.com reported 2025-05-22 that GAITHERSBURG, Md.–(BUSINESS WIRE)–GeneDx (Nasdaq: WGS) today announced that company management will participate in upcoming investor conferences.
Analysts’ Opinion of WGS
Many brokerage firms have already submitted their reports for WGS stocks, with Guggenheim repeating the rating for WGS by listing it as a “Buy.” The predicted price for WGS in the upcoming period, according to Guggenheim is $88 based on the research report published on May 15, 2025 of the current year 2025.
Jefferies, on the other hand, stated in their research note that they expect to see WGS reach a price target of $80. The rating they have provided for WGS stocks is “Buy” according to the report published on May 09th, 2025.
Wells Fargo gave a rating of “Equal Weight” to WGS, setting the target price at $34 in the report published on August 28th of the previous year.
WGS Trading at -21.02% from the 50-Day Moving Average
After a stumble in the market that brought WGS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -42.82% of loss for the given period.
Volatility was left at 13.48%, however, over the last 30 days, the volatility rate increased by 4.31%, as shares sank -38.45% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -26.88% lower at present.
During the last 5 trading sessions, WGS rose by +5.85%, which changed the moving average for the period of 200-days by +138.89% in comparison to the 20-day moving average, which settled at $71.43. In addition, GeneDx Holdings Corp saw -12.40% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at WGS starting from Meister Keith A., who purchase 50,000 shares at the price of $60.16 back on May 14 ’25. After this action, Meister Keith A. now owns 3,058,629 shares of GeneDx Holdings Corp, valued at $3,007,997 using the latest closing price.
Meister Keith A., the Director of GeneDx Holdings Corp, purchase 100,000 shares at $56.01 during a trade that took place back on May 08 ’25, which means that Meister Keith A. is holding 3,008,629 shares at $5,600,994 based on the most recent closing price.
Stock Fundamentals for WGS
Current profitability levels for the company are sitting at:
- -0.04 for the present operating margin
- 0.64 for the gross margin
The net margin for GeneDx Holdings Corp stands at -0.12. The total capital return value is set at -0.04. Equity return is now at value -16.61, with -9.17 for asset returns.
Based on GeneDx Holdings Corp (WGS), the company’s capital structure generated 0.31 points at debt to capital in total, while cash flow to debt ratio is standing at -0.02. The debt to equity ratio resting at 0.45. The interest coverage ratio of the stock is -13.34.
Currently, EBITDA for the company is -23.21 million with net debt to EBITDA at -0.74. When we switch over and look at the enterprise to sales, we see a ratio of 5.86. The receivables turnover for the company is 7.17for trailing twelve months and the total asset turnover is 0.74. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.25.
Conclusion
To wrap up, the performance of GeneDx Holdings Corp (WGS) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
